NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 40 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,113,099 | +50.3% | 26,765,000 | +28.0% | 0.86% | +53.8% |
| Q2 2023 | $26,686,477 | +0.9% | 20,905,000 | +7.7% | 0.56% | +6.1% |
| Q1 2023 | $26,458,771 | +453.3% | 19,405,000 | +544.3% | 0.53% | +361.4% |
| Q4 2022 | $4,781,837 | +11.5% | 3,012,000 | +0.4% | 0.11% | +16.3% |
| Q3 2022 | $4,287,000 | -92.9% | 3,000,000 | -93.4% | 0.10% | -91.7% |
| Q1 2022 | $60,277,000 | +5.3% | 45,447,000 | 0.0% | 1.18% | -1.8% |
| Q4 2021 | $57,226,000 | -6.4% | 45,447,000 | 0.0% | 1.20% | -14.8% |
| Q3 2021 | $61,127,000 | +1.0% | 45,447,000 | 0.0% | 1.40% | +6.9% |
| Q2 2021 | $60,497,000 | -2.2% | 45,447,000 | 0.0% | 1.31% | -17.6% |
| Q1 2021 | $61,849,000 | +1172.6% | 45,447,000 | +1198.5% | 1.59% | +761.1% |
| Q3 2020 | $4,860,000 | – | 3,500,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |